Heritage, FEC to Manage Biopharma Equipment Assets Disposition
Heritage Global Partners and Federal Equipment Company announced they are conducting two global online sales featuring the former assets of Boehringer Ingelheim, Laval R&D site based in Quebec City, Canada. Both global online auctions feature thousands of late model high quality biopharmaceutical laboratory and R&D assets.
The sale includes, among other items, ABI Sciex API 5000 and 4000 QTRAP LCMSMS Systems, Waters Acquity UPLC Systems, ABI DNA Analyzer and 7500 PCR, Agilent Technologies HPLC 1200 and 1100 Series Systems, Bruker 600 and 400 NMR Spectrometers, Dionex UltiMate 3000 Standard LC Systems, MicroMass Platform LCZ and Quatro-II Mass Spectrometers, New Brunswick Scientific FermenterReactors, and much more.
The sale also features large quantities of consumables, freezers, refrigerators, centrifuges, incubators, and other biopharmaceutical laboratory and R&D assets.
“We anticipate strong demand from worldwide buyers as the upcoming global online auctions of the former assets of Boehringer Ingelheim’s Laval laboratory features a broad array of very late model biopharmaceutical technology and equipment from leading manufacturers,” stated Nick Jimenez, director of sales at HGP.
“HGP and FEC are conducting the North American biopharmaceutical asset sales of the year. We have a great selection of laboratory and R&D equipment and we encourage interested bidders to review the upcoming inventory on our website as the partial sale catalogs are now available,” added Jimenez.
Former Assets of Boehringer Ingelheim Laval Laboratory Global Online Auction will be held:
Registration and partial sale catalogs for BI Laval Sale 1 and BI Laval Sale 2 are available on HGP’s website.
Heritage Global Partners is a subsidiary of publicly traded Heritage Global.